- Report
- August 2022
- 329 Pages
Global
From €3503EUR$3,690USD£2,955GBP
- Report
- July 2022
- 385 Pages
Global
From €3645EUR$3,840USD£3,075GBP
- Report
- March 2022
- 210 Pages
Global
From €3389EUR$3,570USD£2,859GBP
- Report
- March 2022
- 231 Pages
Global
From €3384EUR$3,565USD£2,855GBP
- Report
- March 2022
- 230 Pages
Global
From €3281EUR$3,456USD£2,767GBP
- Report
- March 2022
- 256 Pages
Global
From €3384EUR$3,565USD£2,855GBP
- Report
- February 2022
- 229 Pages
Global
From €3524EUR$3,712USD£2,972GBP
- Report
- December 2021
- 257 Pages
Global
From €3524EUR$3,712USD£2,972GBP
- Report
- July 2021
- 295 Pages
Global
From €3524EUR$3,712USD£2,972GBP
- Book
- December 2019
- 312 Pages
- Book
- August 2024
- 272 Pages
- Book
- September 2023
- 288 Pages
- Book
- September 2023
- 288 Pages
- Book
- September 2023
- 3456 Pages
- Book
- March 2023
- 3792 Pages
- Book
- April 2021
- 192 Pages
- Book
- April 2021
- 352 Pages

In Vitro Diagnostics (IVD) is a medical technology used to diagnose diseases and conditions through the analysis of bodily fluids and tissues. It is used to detect, diagnose, and monitor diseases, as well as to assess the effectiveness of treatments. IVD tests are performed in laboratories, hospitals, and other healthcare settings.
IVD tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. They can also be used to monitor the progress of a disease or to assess the effectiveness of a treatment. IVD tests are used to detect and measure the presence of specific molecules, such as proteins, hormones, and enzymes, in a sample.
IVD tests are performed using a variety of technologies, including immunoassays, molecular diagnostics, and flow cytometry. These tests are used to diagnose a wide range of conditions, including infectious diseases, genetic disorders, and cancer.
Some of the major companies in the IVD market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more